Truist Securities Maintains Hold on Zimmer Biomet Holdings, Raises Price Target to $153
Portfolio Pulse from richadhand@benzinga.com
Truist Securities analyst Richard Newitter maintains a 'Hold' rating on Zimmer Biomet Holdings (NYSE:ZBH) and raises the price target from $147 to $153.
July 19, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Truist Securities maintains a 'Hold' rating on Zimmer Biomet Holdings and raises the price target from $147 to $153.
The news is directly about Zimmer Biomet Holdings. The 'Hold' rating suggests that the analyst believes the stock is fairly valued at current levels, and the increase in price target indicates a positive outlook. However, as the rating is not an upgrade, the impact on the stock price in the short term may be neutral.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100